These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36674695)

  • 1. Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1.
    Schöpe PC; Zinnow V; Ishfaq MA; Smith J; Herrmann P; Shoemaker RH; Walther W; Stein U
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis.
    Kortüm B; Radhakrishnan H; Zincke F; Sachse C; Burock S; Keilholz U; Dahlmann M; Walther W; Dittmar G; Kobelt D; Stein U
    Oncogene; 2022 Sep; 41(39):4446-4458. PubMed ID: 36008464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pro-inflammatory TNF-α and IFN-γ Promote Tumor Growth and Metastasis via Induction of MACC1.
    Kobelt D; Zhang C; Clayton-Lucey IA; Glauben R; Voss C; Siegmund B; Stein U
    Front Immunol; 2020; 11():980. PubMed ID: 32670264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MACC1 transcripts in colorectal cancer patient plasma predict metastasis and prognosis.
    Stein U; Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Schlag PM
    PLoS One; 2012; 7(11):e49249. PubMed ID: 23166620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
    Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
    Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.
    Schmid F; Wang Q; Huska MR; Andrade-Navarro MA; Lemm M; Fichtner I; Dahlmann M; Kobelt D; Walther W; Smith J; Schlag PM; Stein U
    Oncogene; 2016 Nov; 35(46):5942-5952. PubMed ID: 26686083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcium-binding protein S100P is a new target gene of MACC1, drives colorectal cancer metastasis and serves as a prognostic biomarker.
    Schmid F; Dahlmann M; Röhrich H; Kobelt D; Hoffmann J; Burock S; Walther W; Stein U
    Br J Cancer; 2022 Sep; 127(4):675-685. PubMed ID: 35597866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.
    Güllü N; Kobelt D; Brim H; Rahman S; Timm L; Smith J; Soleimani A; Di Marco S; Bisti S; Ashktorab H; Stein U
    Cells; 2020 Aug; 9(8):. PubMed ID: 32756469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical relevance of circulating MACC1 and S100A4 transcripts for ovarian cancer.
    Link T; Kuhlmann JD; Kobelt D; Herrmann P; Vassileva YD; Kramer M; Frank K; Göckenjan M; Wimberger P; Stein U
    Mol Oncol; 2019 May; 13(5):1268-1279. PubMed ID: 30927479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.
    Kobelt D; Perez-Hernandez D; Fleuter C; Dahlmann M; Zincke F; Smith J; Migotti R; Popp O; Burock S; Walther W; Dittmar G; Mertins P; Stein U
    Oncogene; 2021 Aug; 40(34):5286-5301. PubMed ID: 34247190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-143 targets MACC1 to inhibit cell invasion and migration in colorectal cancer.
    Zhang Y; Wang Z; Chen M; Peng L; Wang X; Ma Q; Ma F; Jiang B
    Mol Cancer; 2012 Apr; 11():23. PubMed ID: 22533346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
    Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of apoptosis by norcantharidin in human colorectal carcinoma cell lines: involvement of the CD95 receptor/ligand.
    Peng F; Wei YQ; Tian L; Yang L; Zhao X; Lu Y; Mao YQ; Kan B; Lei S; Wang GS; Jiang Y; Wang QR; Luo F; Zou LQ; Liu JY
    J Cancer Res Clin Oncol; 2002 Apr; 128(4):223-30. PubMed ID: 11935314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer.
    Güllü N; Smith J; Herrmann P; Stein U
    Nutrients; 2022 Nov; 14(22):. PubMed ID: 36432477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNPs in the coding region of the metastasis-inducing gene MACC1 and clinical outcome in colorectal cancer.
    Schmid F; Burock S; Klockmeier K; Schlag PM; Stein U
    Mol Cancer; 2012 Jul; 11():49. PubMed ID: 22838389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating Metastasis Associated in Colon Cancer 1 transcripts in gastric cancer patient plasma as diagnostic and prognostic biomarker.
    Burock S; Herrmann P; Wendler I; Niederstrasser M; Wernecke KD; Stein U
    World J Gastroenterol; 2015 Jan; 21(1):333-41. PubMed ID: 25574109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
    Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
    J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of cantharidins on leukemic stem cells.
    Dorn DC; Kou CA; Png KJ; Moore MA
    Int J Cancer; 2009 May; 124(9):2186-99. PubMed ID: 19123473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA target for MACC1 and CYR61 to inhibit tumor growth in mice with colorectal cancer.
    Wang G; Gu J; Gao Y
    Tumour Biol; 2016 Oct; 37(10):13983-13993. PubMed ID: 27492459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-296 inhibits the metastasis and epithelial-mesenchymal transition of colorectal cancer by targeting S100A4.
    He Z; Yu L; Luo S; Li M; Li J; Li Q; Sun Y; Wang C
    BMC Cancer; 2017 Feb; 17(1):140. PubMed ID: 28209128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.